R
Restorbio
Biotech & Life Sciences · Boston, United States · Founded 2016
Innovative medicines targeting aging biology to prevent or treat age-related diseases MoreLess
resTORbio is a biopharmaceutical company focused on developing innovative medicines that target the biology of aging to prevent or treat age-related diseases. The company operates in the healthcare and pharmaceutical market, primarily serving older adults who are at risk of or suffering from chronic diseases associated with aging. resTORbio's business model revolves around the discovery, development, and commercialization of drugs that modulate specific biochemical pathways, such as the TORC1 pathway, which are believed to regulate aging and its related diseases. The company generates revenue through the development and sale of these therapeutic drugs, as well as through partnerships and collaborations with other pharmaceutical companies.
Keywords: biopharmaceutical, aging, innovative medicines, TORC1 pathway, chronic diseases, older adults, healthcare, pharmaceutical, drug development, commercialization.
Company overview
Restorbio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Boston, United States
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 57.0
Valuation & funding
Restorbio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Nov 2017 | $40M | $160M | Rock Springs Capital · OrbiMed · Quan Capital · Nest.Bio Labs | — |
| SERIES AOther financing | Jan 2017 | $25M | $100M | PureTech | — |
Growth signals
Restorbio website traffic
Latest recorded traffic for Restorbio is 340 monthly website visits, down 49.3% over the last three months. Restorbio's team grew 0% over the past year.
Comparisons
Restorbio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 ReViralAntiviral therapeutics targeting respiratory syncytial virus (RSV) |
Stevenage, United Kingdom | Acquired | 5 | $121M | $525M |
 Bio Green Med SolutionClinical-stage biopharma developing cell cycle cancer therapies |
Berkeley Heights, United States | Operational | |||
 CircadiaContactless patient monitoring system for predictive healthcare |
London, United Kingdom | Operational | |||
 TouchStream SolutionsHealth information startup company |
Rochester, United States | Acquired | |||
 InnoVeinInnoVein is revolutionizing vein care with an implantable valve |
San Carlos, United States | Closed | |||
 Ambio HealthWireless health and activity monitoring solutions especially for chronic patients and the elderly |
Stamford, United States | Operational | |||
 HealthsenseHealthsense | Remote Monitoring Services |
Mendota Heights, United States | Operational | |||
 VoCarePersonal care and safety products that help elderly and chronically ill patients |
Indianapolis, United States | Operational |
Talent graph
Restorbio's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Restorbio has talent and traffic
In the news
Latest news about Restorbio
Recent press, funding announcements, and product moves mentioning Restorbio — open to read from the original sources.
Market sentiment
What the market is saying about Restorbio
An AI-synthesized read of the highest-engagement posts about Restorbio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Restorbio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.